Selank 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Selank supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF092025041

Key analytical results include:

• Assay Content: 10.56 mg
• Identification – Retention Time: 0.993
• Identification – Spectrum: 990
• Purity: approximately 99 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Selank is a synthetic peptide research compound frequently studied in controlled laboratory environments examining neuropeptide signalling pathways and regulatory peptide interactions.

The compound is a synthetic analogue derived from the endogenous immunomodulatory peptide tuftsin and has been investigated in experimental models exploring neurochemical signalling and peptide-mediated regulatory processes.

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, Selank has become a widely referenced compound in experimental neuropeptide research models.

Compound Overview

Selank is a synthetic heptapeptide developed as a modified analogue of tuftsin, a naturally occurring peptide involved in immune and regulatory signalling pathways.

Research involving Selank often examines its interaction with neurochemical signalling systems and regulatory peptide pathways.

Experimental models have explored how peptide analogues such as Selank interact with neurotransmitter systems and molecular regulatory networks.

Because of its defined peptide structure and biochemical stability, Selank is frequently utilised in controlled laboratory environments studying neuropeptide-mediated cellular communication.

Historical Background and Scientific Context

Scientific research into regulatory neuropeptides expanded significantly during the late twentieth century as advances in peptide chemistry enabled the synthesis of stable peptide analogues.

During this period researchers began studying synthetic derivatives of naturally occurring peptides that could interact with signalling systems within the nervous and immune systems.

Selank emerged from this research as a synthetic tuftsin-derived peptide analogue used in experimental models investigating neuropeptide signalling mechanisms.

Subsequent studies have explored how synthetic peptide analogues interact with receptor pathways and intracellular signalling networks.

Mechanistic Focus in Research

Within experimental laboratory settings, Selank is commonly studied in relation to neuropeptide signalling and regulatory peptide interaction pathways.

Research investigations commonly explore the compound in experimental models examining:

• Neuropeptide signalling pathways
• Regulatory peptide receptor interactions
• Neurochemical signalling network modelling
• Peptide-mediated cellular communication
• Comparative peptide signalling research
• Molecular regulatory pathway analysis
• Intracellular signalling cascade investigation

These experimental models allow scientists to investigate molecular signalling mechanisms that influence neurochemical communication and cellular regulatory processes.

Research Applications

In controlled research environments, Selank may be utilised in experimental models designed to explore neuropeptide signalling and regulatory peptide systems.

Examples of research applications include:

• Neuropeptide signalling studies
• Regulatory peptide pathway investigation
• Neurochemical signalling analysis
• Peptide receptor interaction research
• Comparative peptide compound evaluation
• Molecular signalling network modelling
• Controlled in vitro peptide studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Verified and analysed with Liquilabs s.r.o. Czechia
• 99 percent purity with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.001 EU per mg
• Batch GF092025041 – Published October 2025
• For research use only – not for human or veterinary use

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.